Carvedilol increases two-year survivalin dialysis patients with dilated cardiomyopathy

Packer, 1996, The effect of carvedilol on morbidity and mortality in patients with chronic heart failure, N Engl J Med, 334, 1349, 10.1056/NEJM199605233342101

1999, The Cardiac Insufficiency Bisoprolol Study (CIBIS-II), Lancet, 349, 9

1999, Effects of metoprolol CR/XL in chronic heart failure, Lancet, 353, 2001

Luke, 1998, Chronic renal failure—a vasculopathic state, N Engl J Med, 339, 841, 10.1056/NEJM199809173391211

U.S. Renal Data System: 1999 annual data report. Am J Kidney Dis 1999;34:S1

Valderrabano, 1996, Report on management of renal failure in Europe. XXV, 1994, Nephrol Dial Transplant, 11, 2, 10.1093/ndt/11.supp1.2

Cice, 2001, Dilated cardiomyopathy in dialysis patients, J Am Coll Cardiol, 37, 407, 10.1016/S0735-1097(00)01158-X

Stack, 1998, Congestive heart failure among incident US dialysis patients, J Am Soc Nephrol, 9, 226A

Harnett, 1995, Congestive heart failure in dialysis patients, Kidney Int, 47, 884, 10.1038/ki.1995.132

Locatelli, 1998, Morbidity and mortality on maintenance haemodialysis, Nephron, 80, 380, 10.1159/000045210

Goodman, 2000, Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis, N Engl J Med, 342, 1478, 10.1056/NEJM200005183422003

Raggi, 2001, Imaging of cardiovascular calcifications with electron beam tomography in hemodialysis patients, Am J Kidney Dis, 37, S62, 10.1053/ajkd.2001.20745

Cice, 2000, Efficacy of carvedilol on complex ventricular arrhythmias in dilated cardiomyopathy, Eur Heart J, 21, 1259, 10.1053/euhj.1999.1984

Converse, 1992, Sympathetic overactivity in patients with chronic renal failure, N Engl J Med, 327, 1912, 10.1056/NEJM199212313272704

Remuzzi, 1999, Sympathetic overactivity in hypertensive patients with chronic renal disease, N Engl J Med, 340, 1360, 10.1056/NEJM199904293401711

Zoccali, 2002, Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease, Circulation, 105, 1354, 10.1161/hc1102.105261

Cice, 1997, A comparative study of carvedilol and controlled release nifedipine in the management of hypertension in chronic haemodialyzed patients, High Blood Pressure, 6, 217

Cice, 1998, Complex ventricular arrhythmias and carvedilol, Cardiologia, 43, 597

Cice, 1997, Comparison of the effects of carvedilol and diltiazem on silent myocardial ischemia in chronic hemodialysis patients, Giorn It Nefrol, 14, 389

Gehr, 1999, The pharmacokinetics of carvedilol and its metabolites after single and multiple dose oral administration in patients with hypertension and renal insufficiency, Eur J Clin Pharmacol, 55, 269, 10.1007/s002280050628

Fuerstein, 1992, Myocardial protection with carvedilol, J Cardiovasc Pharmacol, 19, 5138

Pertosa, 2000, Clinical relevance of cytokine production in hemodialysis, Kidney Int, 76, S104, 10.1046/j.1523-1755.2000.07613.x

Feuerstein, 1996, Carvedilol, a novel vasodilating beta-blocker with the potential for cardiovascular organ protection, Eur Heart J, 17, S24, 10.1093/eurheartj/17.suppl_B.24